The synergistic effect of PD-1 and LAG-3 in promoting tumor immune escape is suggested by studies on CD8+ T cells specific for NY-ESO-1 present in peripheral blood and tumor site of patients with ovarian cancer. This evidence concerns the gene CD8A and ovarian cancer.